Pharma Foods International Co., Ltd. (2929.T)
JPY 934.0
(-0.43%)
JPY 934.0
(-0.43%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.48 Billion | 6.12 Billion | -6.06 Billion | 5.93 Billion | -547.06 Million | 90.65 Million |
| Net Income | 5.03 Billion | 3.54 Billion | 1.42 Billion | 5.76 Billion | 848.65 Million | 668.57 Million |
| Depreciation & Amortization | 907 Million | 546 Million | 520 Million | 181 Million | 151.84 Million | 91.53 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 121 Million | 2.97 Billion | -4.46 Billion | -793 Million | -1.03 Billion | -689.19 Million |
| Other non-cash items | -576 Million | -937 Million | -3.53 Billion | 785 Million | -513.4 Million | 19.73 Million |
| Investing Cash Flow | -1.39 Billion | -1.01 Billion | -2.53 Billion | -442 Million | -860.93 Million | -301.06 Million |
| Investments in PPE | -973 Million | -405 Million | -472 Million | -173 Million | -913.32 Million | -280.62 Million |
| Acquisitions | - | -16 Million | -1.59 Billion | -30 Million | - | 10.21 Million |
| Investment purchases | -463 Million | -700 Million | -1.02 Billion | -200 Million | - | -11.28 Million |
| Sales/Maturities of investments | 53 Million | 100 Million | 300 Million | 23 Million | 22.16 Million | 1.09 Million |
| Other Investing Activities | -38 Million | 8 Million | 253 Million | -62 Million | 30.22 Million | -20.46 Million |
| Financing Cash Flow | -4.84 Billion | 2.34 Billion | 7.67 Billion | 1.03 Billion | 375.62 Million | 1.59 Billion |
| Debt repayment | -3.2 Billion | -760 Million | -3.24 Billion | -1.18 Billion | -1.19 Billion | -805.45 Million |
| Dividends payments | -626 Million | -578 Million | -871 Million | -290 Million | -101.64 Million | - |
| Common Stock Repurchased | -999 Million | -300 Million | -299 Million | 2.5 Billion | 1.66 Billion | -98 Million |
| Common Stock Issuance | - | 2 Million | 5 Million | 8 Million | 2.58 Million | 1.58 Million |
| Other Financing Activities | -12 Million | 3.97 Billion | 12.08 Billion | -8 Million | 3.32 Million | 2.59 Billion |
| Accounts receivables | 287 Million | 3.49 Billion | -1.52 Billion | -2.67 Billion | -958.14 Million | -377.52 Million |
| Accounts payables | 313 Million | -238 Million | -615 Million | 396 Million | 183.23 Million | 67.7 Million |
| Inventory | -649 Million | 12 Million | -2.24 Billion | -1.07 Billion | -612.26 Million | -426.31 Million |
| Other working capital | 483 Million | -292 Million | -80 Million | 2.55 Billion | 353.01 Million | 46.93 Million |
| Cash at beginning of period | 16.3 Billion | 8.84 Billion | 9.79 Billion | 3.28 Billion | 4.31 Billion | 2.93 Billion |
| Cash at end of period | 15.56 Billion | 16.3 Billion | 8.84 Billion | 9.79 Billion | 3.28 Billion | 4.31 Billion |
| Capital Expenditure | -973 Million | -405 Million | -472 Million | -173 Million | -913.32 Million | -280.62 Million |
| Effect of forex changes on cash | 5 Million | 5 Million | -22 Million | -14 Million | -1.76 Million | -1.25 Million |
| Net cash flow / Change in cash | -740 Million | 7.46 Billion | -949 Million | 6.51 Billion | -1.03 Billion | 1.38 Billion |
| Free Cash Flow | 4.51 Billion | 5.72 Billion | -6.53 Billion | 5.76 Billion | -1.46 Billion | -189.96 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.34 Billion | 1.08 Billion | 482 Million | 286 Million | 3.54 Billion | 2.01 Billion |
| Depreciation & Amortization | - | - | - | 144 Million | 546 Million | 151 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | 2.97 Billion | - |
| Other non-cash items | -1.34 Billion | -1.08 Billion | -482 Million | -286 Million | -937 Million | -2.01 Billion |
| Investing Cash Flow | - | - | - | - | -1.01 Billion | - |
| Investments in PPE | - | - | - | - | -405 Million | - |
| Acquisitions | - | - | - | - | -16 Million | - |
| Investment purchases | - | - | - | - | -700 Million | - |
| Sales/Maturities of investments | - | - | - | - | 100 Million | - |
| Other Investing Activities | - | - | - | - | 8 Million | - |
| Financing Cash Flow | - | - | - | - | 2.34 Billion | - |
| Debt repayment | - | - | - | - | -760 Million | - |
| Dividends payments | - | - | - | - | -578 Million | - |
| Common Stock Repurchased | - | - | - | - | -300 Million | - |
| Common Stock Issuance | - | - | - | - | 2 Million | - |
| Other Financing Activities | - | - | - | - | 3.97 Billion | - |
| Accounts receivables | - | - | - | - | 3.49 Billion | - |
| Accounts payables | - | - | - | - | -238 Million | - |
| Inventory | - | - | - | - | 12 Million | - |
| Other working capital | - | - | - | - | -292 Million | - |
| Cash at beginning of period | - | - | - | 16.3 Billion | 8.84 Billion | 13.88 Billion |
| Cash at end of period | - | - | - | 17.42 Billion | 16.3 Billion | 16.3 Billion |
| Capital Expenditure | - | - | - | - | -405 Million | - |
| Effect of forex changes on cash | - | - | - | - | 5 Million | - |
| Net cash flow / Change in cash | - | - | - | 1.12 Billion | 7.46 Billion | 2.42 Billion |
| Free Cash Flow | - | - | - | 288 Million | 5.72 Billion | 302 Million |
FOF
600517
4549
BBSS
CARA
BME